Millennium Management »

Sab Biotherapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $164k 53k 3.10
2024-03-31 $245k 54k 4.54

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
NVIDIA Corporation Put Option (NVDA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Put Option (MSFT)
Amazon Put Option (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Tesla Motors (TSLA)
Broadcom Put Option (AVGO)
Ishares Tr Msci Emg Mkt Etf (EEM)
Advanced Micro Devices Put Option (AMD)
Merck & Co Call Option (MRK)

View all positions for Millennium Management

Top funds holding Sab Biotherapeutics

BVF
Marshall Wace
Sessa Capital IM
Vanguard Group
HB Wealth Management
Geode Capital Management
Millennium Management
Pathstone Holdings
First Manhattan
First PREMIER Bank
Institutional & Family Asset Management
BlackRock
Tower Research Capital
Morgan Stanley
Princeton Global Asset Management

View all funds holding Sab Biotherapeutics